Confidence in Therapy Diagnostics
With innovative far-field signal reduction technology, the OptiSense lead effectively reduces inappropriate mode switching thereby maintaining A-V synchrony. Clarified atrial sensing provides accurate atrial diagnostics and therapies.
More Options in Targeted Lead Placement
Targeted lead placement is increasingly common as physicians seek ways to pace the heart more physiologically. Placing an atrial lead too close to the ventricle could result in far-field R-wave oversensing and inappropriate therapy and diagnostics. In reducing far-field ventricular signals, OptiSense lead technology allows for more options in atrial lead placement.
High Performance
- Shorter tip-to-ring spacing – 1.1 mm - exclusive lead technology, designed to reduce ventricular oversensing, while maintaining near-field P-wave sensing. Accurate sensing reduces inappropriate mode switching, maintaining A-V synchrony.
- Excellent fluoroscopic visibility – designed to provide easy verification of helix extension/retraction. A main part of the housing material on the tip is constructed of titanium, which is transparent on fluoroscopy. Radiopaque markers underneath the housing make it possible to verify helix extension/retraction.
- Silicone insulation with Fast-Pass™ coating – facilitates lead insertion through the introducer and the veins.
- Multiple Lengths (40, 46 and 52 cm) – provide the flexibility to choose the best length for each individual patient.
- Thin lead body diameter – only 6.2 F - provides ease of passage, facilitates small venous puncture and preserves venous space. The lead can be inserted using a 7 F introducer.
- Lower thresholds with steroid elution – designed to reduce tissue inflammation at the lead/tissue interface. It also promotes low stimulation thresholds.
- Reduced polarization with titanium nitride fractal coating – designed to promote precise sensing and to provide improved contact with the myocardium.
| 
